New GDP Guidelines will be a Real Challenge for Wholesalers
Add bookmark
New GDP Guidelines will be a Real Challenge for Wholesalers
Add bookmarkThe European Commission issued final revised Good Distribution Practices (GDP) guidelines on 8 March 2013.
In this exclusive interview Thomas Brýckner, Head of Pharmaceutical Affairs/ Medical Devices/ CAM of The German Pharmaceutical Industry Assosciation (BPI), speaks to Andrea Charles from Cold Chain IQ, about how revised guidelines on good distribution practice will impact wholesalers and controlled room temperature (CRT) logistics for pharmaceutical products. Brýckner also shares his top tip for ensuring a secure and compliant product supply chain and updates us on the progress of the SecurPharm Project.
[inlinead]
| Have Your Say Rate this feature and give us your feedback in the comments section below |
Tags:
GDP guidelines
BPI
German pharma industry
FMD directive
German Pharmaceutical Industry Assosciation
Thomas Brückner
Good Distribution Practice
SecurPharm Project
Falsified Medicines Directive
falsified medicines
revised GDP guidelines
new GDP guidelines
